US Patent 11208383 KCNQ potentiators
Patent 11208383 was granted and assigned to Eli Lilly and Company on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+486 characters)
Article
Patent abstract
Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—which are also called KCNQ potentiators), compositions including such compounds, and methods of using such compounds for the treatment of Amyotrophic Lateral Sclerosis and other neurological diseases caused by changes in motor neuron excitability, including, but not limited to, primary lateral sclerosis, pseudobulbar palsy, progressive bulbar palsy, progressive muscular atrophy and epilepsy.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112083830
Date of Patent
December 28, 2021
0Patent Application Number
167811480
Date Filed
February 4, 2020
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112083830
Date of Patent
December 28, 2021
0Patent Application Number
167811480
Date Filed
February 4, 2020
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11208383 KCNQ potentiators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11208383
Date of patent
December 28, 2021
Patent application number
16781148
Date Filed
February 4, 2020
Patent primary examiner
Find more entities like US Patent 11208383 KCNQ potentiators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
